Envisagenics Inc.

NY

UEI
DDJBJ4APF8S3
CAGE
76UL8
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Hispanic American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
30-02 48th Ave #290, Long Island City, NY 11101, USA
Website
envisagenics.com
Founded
2014
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Splicedisco: a machine learning tool for the identification of alternative splicing events directly regulated by… R44CA310213 National Cancer Institute (NIH) $889,653
Comprehensive validation and commercial readiness of spliceio, a software platform for neoantigen discovery using… R44CA265446 National Cancer Institute (NIH) $4,073,854
A software platform for the identification of cell surface antigens using RNA-SEQ data R43CA246950 National Cancer Institute (NIH) $301,502
Splicecore: a cloud-based platform to detect, quantify and interpret alternative splicing variation from… R43GM116478 National Institutes of Health $225,000
Splicecore: a cloud-based software platform to translate alternative splicing events into therapeutic targets using… R44GM116478 National Institute of General Medical Sciences (NIH) $1,625,000

Quick answers

Is Envisagenics Inc. registered in SAM.gov?

Yes. Envisagenics Inc.'s SAM.gov registration is active through January 28, 2027.

What is Envisagenics Inc.'s most recent federal award?

Envisagenics Inc.'s most recent federal grant award is Splicedisco: a machine learning tool for the identification of alternative splicing events directly regulated by… (R44CA310213), from National Cancer Institute (NIH), on August 1, 2026.

On GovTribe

See Envisagenics Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login